Richard Douglas, PhD

Dr. Douglas joined the Novavax board of directors in 2010. He has more than 25 years of biotechnology experience having served in corporate development roles at Genzyme Corporation since 1989. Most recently, Dr. Douglas was senior vice president of corporate development and a corporate officer at Genzyme Corporation. As a leader of Genzyme’s corporate development team, Dr. Douglas was involved in numerous acquisitions, licenses, joint ventures, and strategic alliances. From 1982 until its merger with Genzyme Corporation in 1989, Dr. Douglas served in science and corporate development capacities at Integrated Genetics. Dr. Douglas was a postdoctoral fellow in Leroy Hood’s laboratory at the California Institute of Technology. He received a BS in chemistry from the University of Michigan and a PhD from the University of California, Berkeley in biochemistry. He currently serves on the University of Michigan Technology Transfer National Advisory Board.